Matches in Nanopublications for { ?s ?p "[FCGR2A and FCGR3A polymorphisms associated with clinical outcome of epidermal growth factor receptor expressing metastatic colorectal cancer patients treated with single-agent cetuximab.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 10 of
10
with 100 items per page.
- NP362026.RAZBCopTSYERzauG9rUjsqLe2sJd0ei1Qetq34ZKambZ4130_assertion description "[FCGR2A and FCGR3A polymorphisms associated with clinical outcome of epidermal growth factor receptor expressing metastatic colorectal cancer patients treated with single-agent cetuximab.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP362026.RAZBCopTSYERzauG9rUjsqLe2sJd0ei1Qetq34ZKambZ4130_provenance.
- NP749182.RAQ3t402AS7IgyTyQxYPfjs-yadQAM2E0zoUGv-7fd0CY130_assertion description "[FCGR2A and FCGR3A polymorphisms associated with clinical outcome of epidermal growth factor receptor expressing metastatic colorectal cancer patients treated with single-agent cetuximab.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP749182.RAQ3t402AS7IgyTyQxYPfjs-yadQAM2E0zoUGv-7fd0CY130_provenance.
- NP397272.RAAo6AjNQ9u3ztxaN5x0m8rkvQ3QYyvucGRdMsZyTH8Mw130_assertion description "[FCGR2A and FCGR3A polymorphisms associated with clinical outcome of epidermal growth factor receptor expressing metastatic colorectal cancer patients treated with single-agent cetuximab.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP397272.RAAo6AjNQ9u3ztxaN5x0m8rkvQ3QYyvucGRdMsZyTH8Mw130_provenance.
- assertion description "[FCGR2A and FCGR3A polymorphisms associated with clinical outcome of epidermal growth factor receptor expressing metastatic colorectal cancer patients treated with single-agent cetuximab.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[FCGR2A and FCGR3A polymorphisms associated with clinical outcome of epidermal growth factor receptor expressing metastatic colorectal cancer patients treated with single-agent cetuximab.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[FCGR2A and FCGR3A polymorphisms associated with clinical outcome of epidermal growth factor receptor expressing metastatic colorectal cancer patients treated with single-agent cetuximab.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP625683.RA5HmyC4-SNsRTKjXX4hl2Y0gPBsUgRY7xdM86cCa0_Eo130_assertion description "[FCGR2A and FCGR3A polymorphisms associated with clinical outcome of epidermal growth factor receptor expressing metastatic colorectal cancer patients treated with single-agent cetuximab.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625683.RA5HmyC4-SNsRTKjXX4hl2Y0gPBsUgRY7xdM86cCa0_Eo130_provenance.
- NP625684.RA7h9lBl-2h7f-edesGcWf2WZqT6vQNNpRdPeEb6cWDnQ130_assertion description "[FCGR2A and FCGR3A polymorphisms associated with clinical outcome of epidermal growth factor receptor expressing metastatic colorectal cancer patients treated with single-agent cetuximab.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625684.RA7h9lBl-2h7f-edesGcWf2WZqT6vQNNpRdPeEb6cWDnQ130_provenance.
- NP625687.RA7lQL6C4XCNjILS0fod-JQmDKS65EACjHpeUJI92Lgvk130_assertion description "[FCGR2A and FCGR3A polymorphisms associated with clinical outcome of epidermal growth factor receptor expressing metastatic colorectal cancer patients treated with single-agent cetuximab.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625687.RA7lQL6C4XCNjILS0fod-JQmDKS65EACjHpeUJI92Lgvk130_provenance.
- NP396851.RAqiXPnu33ZBE5AAr0snvfpoGqINJVcl11pjtsj5L_FXM130_assertion description "[FCGR2A and FCGR3A polymorphisms associated with clinical outcome of epidermal growth factor receptor expressing metastatic colorectal cancer patients treated with single-agent cetuximab.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP396851.RAqiXPnu33ZBE5AAr0snvfpoGqINJVcl11pjtsj5L_FXM130_provenance.